John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 24,999 shares at $15.97 ($386K) on 2018-10-01, disclosed to the SEC on 2018-10-03.
Open-market sale of $386k ALDR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 18,445 | $281K | 72.9% |
| 2 | $15.97 | 6,554 | $105K | 27.1% |
| Total | $15.44 avg | 24,999 | $386K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |